Aurora Healthcare US CorpFebruary 17, 2022

FDA 483 - Aurora Healthcare US Corp - February 17, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurora Healthcare US Corp

Record Details

An FDA inspection of Aurora Healthcare US Corp in Danvers, MA, a manufacturer of the Aurora Dedicated Breast MRI System, revealed multiple significant procedural deficiencies. Observations included inadequate procedures for supplier quality management, corrective and preventive actions, complaint handling, management review, and quality audits. One observation regarding supplier re-evaluation was a repeat finding, indicating a persistent lack of compliance.

Company: Aurora Healthcare US Corp
Inspection Date: February 17, 2022
Product Type: Device
Office: Division of Northeast Imports
Person: James P. Finn (investigator)

Open in Dashboard

ID · a4fe15f3-63e5-45ed-87c8-852db1ccdd35